期刊文献+

平喘固本汤合补肺汤治疗肺肾气虚型慢性阻塞性肺疾病的临床效果观察 被引量:11

Clinical efficacy of the Pingchuan Guben decoction plus the Bufei decoction on COPD of the Feishen Qixu type
下载PDF
导出
摘要 目的:探讨肺肾气虚型慢性阻塞性肺疾病(COPD)患者应用平喘固本汤合补肺汤治疗的临床价值。方法:选取我院2014年8月-2016年8月收治的肺肾气虚型COPD患者82例为研究对象,经随机数字表法分为观察组与对照组,对照组给予西医常规治疗,观察组在对照组基础上给予平喘固本汤合补肺汤治疗。观察两组患者效果及肺功能变化。结果:观察组与对照组治疗总有效率分别为92.68%、75.61%,观察组显著较高,差异有统计学意义(P<0.05);治疗前两组患者肺功能指标无显著差异(P>0.05),治疗后均有改善,观察组治疗后FEV1、FEV1/FVC同对照组比较,明显较高,差异有统计学意义(P<0.05)。结论:肺肾气虚型COPD患者应用平喘固本汤合补肺汤治疗,效果确切,可有效缓解症状,改善肺功能,值得推广。 Objective:To investigate clinical efficacy of the Pingchuan Guben decoction plus the Bufei decoction on COPD of the Feishen Qixu type.Methods:82patients were divided into2groups.The control group was given the western medicine;and the observation group was given the Pingchuan Guben decoction plus the Bufei decoction more.Efficiency and lung function change in groups were observed.Results:The total efficiency was92.68%in the observation group,better than75.61%in the control group(P<0.05).After treatment,the levels of FEV1and FEV1/FVC in the observation group were significantly higher than those in the control group(P<0.05).Conclusion:The Pingchuan Guben decoction plus the Bufei decoction on COPD of the Feishen Qixu type shows a good effect,and is worthy of promotion.
作者 周晔
出处 《中医临床研究》 2017年第28期59-60,共2页 Clinical Journal Of Chinese Medicine
关键词 慢性阻塞性肺疾病 肺肾气虚证 中医药 肺功能 COPD The Feishen Qixu type TCM medicine Lung function
  • 相关文献

参考文献6

二级参考文献49

  • 1姜静,奚肇庆.慢性阻塞性肺疾病病机探析[J].南京中医药大学学报,2006,22(3):147-149. 被引量:17
  • 2王胜,徐凤珍,陈余清.慢性阻塞性肺疾病患者痰液炎症细胞计数与分类及其意义[J].临床内科杂志,2006,23(6):385-387. 被引量:4
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1789
  • 5周仲瑛.中医内科学[M].2版.北京:中国中医药出版社,2007:379.
  • 6Jones PW. Health status and the spiral of decline. COPD,2009 ,6: 59-63.
  • 7GOLD Executive Committee. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonarydisease ( Revised 2011 ) [ EB/OL ] . [ 2013-04-06 ] . http ;//www. goldcopd. com.
  • 8Soriano JB, Alfageme I,Almagro P, et al. Distribution andprognostic validity of the new GOLD grading classification. Chest,2013, 143: 694-702.
  • 9Lange P, Marott JL, Vestbo J, et al. Prediction of (he clinicalcourse of chronic obstructive pulmonary disease, using the newGOLD classification : a study of the general population. Am JRespir Crit Care Med, 2012,186: 975-981.
  • 10Jones P, Adamek L, Nadeau G, et al. Comparisons of healthstatus scores with MRC grades in a primary care COPD population :implications for the new GOLD 2011 classification. Eur Respir J ,2012 , Dec 20. Epub ahead of print.

共引文献143

同被引文献188

引证文献11

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部